Results 131 to 140 of about 43,790 (213)

Examination of scenarios introducing rubella vaccine in the Democratic Republic of the Congo. [PDF]

Vaccine X, 2021
Cheng A, Frey K, Mwamba GN, McCarthy KA, Hoff NA, Rimoin AW.   +5 more
europepmc   +1 more source

A Comparative Prospective Study to Assess Efficacy of Intralesional MMR (Measles, Mumps, Rubella) Vaccine and Intralesional Vitamin D3 in Treatment of Nongenital Warts. [PDF]

Health Sci Rep
Baaniya B, Marahatta S, Dahal R, Shah N.
europepmc   +1 more source

Measles, mumps and rubella vaccine and heterologous immunity: a way out of the COVID-19 crisis? [PDF]

Sudan J Paediatr, 2022
Shrivastava J, Narang M, Gomber S.
europepmc   +1 more source

Intralesional Measles, Mumps and Rubella Vaccine versus Formic Acid Puncture in the Treatment of Common Warts: A Prospective Randomised Study.

Indian J Dermatol, 2023
D'Souza MJ, Hundi GK, Dandekeri S, Jayaraman J.   +3 more
europepmc   +1 more source

Intralesional Immunotherapy with Measles-Mumps-Rubella Vaccine for Recalcitrant Facial Warts: A Report of Two Cases. [PDF]

Oman Med J, 2022
Al-Qassabi AM, Al Kindi A.
europepmc   +1 more source

Neutralization of Rubella Vaccine Virus and Immunodeficiency-Related Vaccine-Derived Rubella Viruses by Intravenous Immunoglobulins. [PDF]

J Infect Dis
Chen MH, Perelygina L, Hao L, Beard RS, Lackner C, Farcet MR, Karbiener M, Icenogle J, Kreil TR.   +8 more
europepmc   +1 more source

A Comparative Analysis of Efficacy of Intralesional Mumps-Measles-Rubella Vaccine Versus 5-Fluorouracil in the Treatment of Palmoplantar Warts. [PDF]

Indian Dermatol Online J, 2022
Sunny AS, Doshi BR.
europepmc   +1 more source

The Oncogenic Human Papillomavirus Involvement as a Risk Factor of Measles, Mumps, and Rubella Vaccine Immunotherapy Failure in Anogenital Warts. [PDF]

Int Med Case Rep J
Achdiat PA, Ismiranty D, Hindritiani R, Rizqandaru T, Usman HA, Maharani RH.   +5 more
europepmc   +1 more source

Multiplexed VaxArray immunoassay for rapid antigen quantification in measles and rubella vaccine manufacturing. [PDF]

Vaccine X, 2021
Gillis JH, Thomas KN, Manoharan S, Panchakshari M, Taylor AW, Miller DF, Byrne-Nash RT, Riley C, Rowlen KL, Dawson E.   +9 more
europepmc   +1 more source

Immunogenicity and safety of measles-mumps-rubella vaccine delivered by the aerosol, intradermal and intramuscular routes in previously vaccinated young adults: a randomized controlled trial protocol. [PDF]

PLoS One
Saha S, Millier M, Samaranayaka A, Edmonds L, Best E, Ussher J, Anglemyer A, Lee J, Tatley M, Cutts F, van Binnendijk R, McIntyre P.   +11 more
europepmc   +1 more source